51. SARS‐CoV‐2 and myasthenia
- Author
-
Ana C Fiorini, Fulvio A. Scorza, Carla A. Scorza, and Josef Finsterer
- Subjects
Adult ,Male ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Exacerbation ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,education ,Cross Reactions ,Antibodies, Viral ,03 medical and health sciences ,Epitopes ,Immunocompromised Host ,0302 clinical medicine ,Muscular Diseases ,Virology ,Acetyl choline receptor ,Pandemic ,Myasthenia Gravis ,Medicine ,Humans ,Receptors, Cholinergic ,030212 general & internal medicine ,Aged ,Aged, 80 and over ,business.industry ,SARS-CoV-2 ,COVID-19 ,Middle Aged ,Infectious Diseases ,030211 gastroenterology & hepatology ,Female ,business - Abstract
The COVID-19 pandemic due to infection with SARS-CoV-2 not only affects political, economic, social, and cultural life, but also has a significant impact on medicine. This article is protected by copyright. All rights reserved.
- Published
- 2021
- Full Text
- View/download PDF